1. Home
  2. JJSF vs NNNN Comparison

JJSF vs NNNN Comparison

Compare JJSF & NNNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JJSF
  • NNNN
  • Stock Information
  • Founded
  • JJSF 1971
  • NNNN 2021
  • Country
  • JJSF United States
  • NNNN Germany
  • Employees
  • JJSF N/A
  • NNNN N/A
  • Industry
  • JJSF Specialty Foods
  • NNNN Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • JJSF Consumer Staples
  • NNNN Health Care
  • Exchange
  • JJSF Nasdaq
  • NNNN Nasdaq
  • Market Cap
  • JJSF 2.1B
  • NNNN 2.2B
  • IPO Year
  • JJSF N/A
  • NNNN 2025
  • Fundamental
  • Price
  • JJSF $103.82
  • NNNN $43.18
  • Analyst Decision
  • JJSF Buy
  • NNNN
  • Analyst Count
  • JJSF 2
  • NNNN 0
  • Target Price
  • JJSF $142.50
  • NNNN N/A
  • AVG Volume (30 Days)
  • JJSF 119.3K
  • NNNN 61.5K
  • Earning Date
  • JJSF 11-12-2025
  • NNNN 01-01-0001
  • Dividend Yield
  • JJSF 3.01%
  • NNNN N/A
  • EPS Growth
  • JJSF N/A
  • NNNN N/A
  • EPS
  • JJSF 4.29
  • NNNN 0.06
  • Revenue
  • JJSF $1,599,746,000.00
  • NNNN $8,185,146.00
  • Revenue This Year
  • JJSF $4.52
  • NNNN N/A
  • Revenue Next Year
  • JJSF $2.86
  • NNNN N/A
  • P/E Ratio
  • JJSF $24.22
  • NNNN $798.71
  • Revenue Growth
  • JJSF 0.49
  • NNNN 21.95
  • 52 Week Low
  • JJSF $103.76
  • NNNN $5.18
  • 52 Week High
  • JJSF $180.80
  • NNNN $55.65
  • Technical
  • Relative Strength Index (RSI)
  • JJSF 32.19
  • NNNN N/A
  • Support Level
  • JJSF $104.49
  • NNNN N/A
  • Resistance Level
  • JJSF $108.56
  • NNNN N/A
  • Average True Range (ATR)
  • JJSF 2.56
  • NNNN 0.00
  • MACD
  • JJSF -0.58
  • NNNN 0.00
  • Stochastic Oscillator
  • JJSF 0.00
  • NNNN 0.00

About JJSF J & J Snack Foods Corp.

J&J Snack Foods Corp manufactures, markets, and distributes snack foods and beverages to foodservice and retail supermarket outlets. The company's products include frozen beverages, juice, fruit bars, sorbet, cakes, and cookies that are distributed to various consumers, including restaurants, supermarkets, convenience stores, universities, theaters, and theme parks. The company operates in three business segments: food service, which sells snacks, desserts, and baked goods at the point-of-sale; retail supermarkets, which sells frozen and prepackaged products to supermarkets; and frozen beverages, which sells frozen beverages under brands Icee, Slush puppie, and Parrot ice in the United States, Mexico, and Canada.

About NNNN Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.

Share on Social Networks: